Lakeshore Biopharma Co Stock Net Income
| LSBCF Stock | 0.85 0.00 0.00% |
As of the 22nd of January, LakeShore Biopharma secures the Risk Adjusted Performance of 0.0451, downside deviation of 5.7, and Mean Deviation of 1.08. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LakeShore Biopharma, as well as the relationship between them. Please verify LakeShore Biopharma information ratio and the relationship between the maximum drawdown and skewness to decide if LakeShore Biopharma Co is priced some-what accurately, providing market reflects its recent price of 0.85 per share. Given that LakeShore Biopharma is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.
LakeShore Biopharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LakeShore Biopharma's valuation are provided below:LakeShore Biopharma Co does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. LakeShore | Build AI portfolio with LakeShore Stock |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LakeShore Biopharma is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LakeShore Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LakeShore Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LakeShore Biopharma.
| 10/24/2025 |
| 01/22/2026 |
If you would invest 0.00 in LakeShore Biopharma on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding LakeShore Biopharma Co or generate 0.0% return on investment in LakeShore Biopharma over 90 days. More
LakeShore Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LakeShore Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LakeShore Biopharma Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.7 | |||
| Information Ratio | 0.0109 | |||
| Maximum Drawdown | 15.86 | |||
| Value At Risk | (2.35) | |||
| Potential Upside | 2.44 |
LakeShore Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LakeShore Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LakeShore Biopharma's standard deviation. In reality, there are many statistical measures that can use LakeShore Biopharma historical prices to predict the future LakeShore Biopharma's volatility.| Risk Adjusted Performance | 0.0451 | |||
| Jensen Alpha | 0.1577 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | 0.0049 | |||
| Treynor Ratio | (0.32) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma January 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0451 | |||
| Market Risk Adjusted Performance | (0.31) | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 2.0 | |||
| Downside Deviation | 5.7 | |||
| Coefficient Of Variation | 1942.57 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.58 | |||
| Information Ratio | 0.0109 | |||
| Jensen Alpha | 0.1577 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | 0.0049 | |||
| Treynor Ratio | (0.32) | |||
| Maximum Drawdown | 15.86 | |||
| Value At Risk | (2.35) | |||
| Potential Upside | 2.44 | |||
| Downside Variance | 32.46 | |||
| Semi Variance | 4.01 | |||
| Expected Short fall | (2.67) | |||
| Skewness | (0.23) | |||
| Kurtosis | 17.38 |
LakeShore Biopharma Backtested Returns
At this point, LakeShore Biopharma is dangerous. LakeShore Biopharma has Sharpe Ratio of 0.0515, which conveys that the firm had a 0.0515 % return per unit of risk over the last 3 months. We have found twenty-five technical indicators for LakeShore Biopharma, which you can use to evaluate the volatility of the firm. Please verify LakeShore Biopharma's Downside Deviation of 5.7, mean deviation of 1.08, and Risk Adjusted Performance of 0.0451 to check out if the risk estimate we provide is consistent with the expected return of 0.13%. LakeShore Biopharma has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.38, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning LakeShore Biopharma are expected to decrease at a much lower rate. During the bear market, LakeShore Biopharma is likely to outperform the market. LakeShore Biopharma right now secures a risk of 2.57%. Please verify LakeShore Biopharma Co total risk alpha, downside variance, day median price, as well as the relationship between the maximum drawdown and skewness , to decide if LakeShore Biopharma Co will be following its current price movements.
Auto-correlation | 0.64 |
Good predictability
LakeShore Biopharma Co has good predictability. Overlapping area represents the amount of predictability between LakeShore Biopharma time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LakeShore Biopharma price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current LakeShore Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, LakeShore Biopharma Co reported net income of (99.98 Million). This is 129.3% lower than that of the Healthcare sector and 242.74% lower than that of the Biotechnology industry. The net income for all United States stocks is 117.51% higher than that of the company.
LakeShore Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in net income category among its peers.
LakeShore Fundamentals
| Revenue | 614.96 M | |||
| EBITDA | (48.54 M) | |||
| Net Income | (99.98 M) | |||
| Total Debt | 414.4 M | |||
| Cash Flow From Operations | (120.98 M) | |||
| Number Of Employees | 758 | |||
| Total Asset | 1.37 B | |||
| Retained Earnings | (2.41 B) | |||
| Working Capital | 17.47 M | |||
| Net Asset | 1.37 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether LakeShore Biopharma is a strong investment it is important to analyze LakeShore Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LakeShore Biopharma's future performance. For an informed investment choice regarding LakeShore Stock, refer to the following important reports:Check out LakeShore Biopharma Piotroski F Score and LakeShore Biopharma Altman Z Score analysis. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LakeShore Biopharma is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.